Fennec Pharmaceuticals Inc (FENC) Straddle

Trading a FENC straddle lets you take a pure volatility position on Fennec Pharmaceuticals Inc without committing to a direction. Fennec Pharmaceuticals Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate FENC straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on FENC profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Fennec Pharmaceuticals Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the FENC straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the FENC straddle is the cleanest expression of that view. Our scanner prices every FENC straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a FENC straddle into a catalyst or short a FENC straddle to harvest decay, the options straddle setups that matter are all in one place.